Further, we believe the current group identified with postponed basal insulin-initiation, despite the potential exclusion of subjects referred to an outpatient diabetes clinic, still represents a clinically relevant sample of patients highly affected by therapeutic inertia. The gene discussed is INS; the disease is diabetes mellitus.